↓ Skip to main content

A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus

Overview of attention for article published in Frontiers in immunology, April 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news
1 news outlet
twitter
3 X users

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
34 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus
Published in
Frontiers in immunology, April 2021
DOI 10.3389/fimmu.2021.664212
Pubmed ID
Authors

Fabián E. Díaz, Mariana Guerra-Maupome, Paiton O. McDonald, Daniela Rivera-Pérez, Alexis M. Kalergis, Jodi L. McGill

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 34 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 21%
Student > Master 4 12%
Student > Doctoral Student 2 6%
Student > Bachelor 2 6%
Librarian 1 3%
Other 0 0%
Unknown 18 53%
Readers by discipline Count As %
Veterinary Science and Veterinary Medicine 5 15%
Biochemistry, Genetics and Molecular Biology 2 6%
Nursing and Health Professions 2 6%
Immunology and Microbiology 2 6%
Agricultural and Biological Sciences 1 3%
Other 3 9%
Unknown 19 56%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 May 2022.
All research outputs
#3,064,348
of 25,387,668 outputs
Outputs from Frontiers in immunology
#3,204
of 31,541 outputs
Outputs of similar age
#76,443
of 453,287 outputs
Outputs of similar age from Frontiers in immunology
#160
of 1,325 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 31,541 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 453,287 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 1,325 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.